Areca nut extracts increased the expression of cyclooxygenase-2, prostaglandin E2 and interleukin-1α in human immune cells via oxidative stress

Archives of Oral Biology

Volumn 58, Issue 10, 2013, Pages 1523-1531

  Chang, Lien Yu ^a,b,c   Wan, Hsiao Ching ^a   Lai, Yu Lin ^a,c   Chou, I Chiang ^a,b,c   Chen, Yen Ting ^a   Hung, Shan Ling ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Antioxidant; Areca nut extract; Cyclooxygenase 2; Interleukin 1 ; Peripheral blood mononuclear cells

Indexed keywords

ARECA CATECHU; PIPER BETEL;

ANTIOXIDANT; ARECA NUT EXTRACT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; NSAIDS; PLANT EXTRACT; PROSTAGLANDIN E2; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE;

ACTIVATOR PROTEIN-1; ADULT; ANE; AP-1; AQ; ARECA; ARECA QUID; ARTICLE; CELL CULTURE; COX-2; CYCLOOXYGENASE-2; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IL-1Α; IL-1Β; INTERLEUKIN-1Α; INTERLEUKIN-1Β; MALE; METABOLISM; MONONUCLEAR CELL; MOUTH SQUAMOUS CELL CARCINOMA; NF-ΚB; NONSTEROIDAL ANTI-INFLAMMATORY DRUGS; NUCLEAR FACTOR-ΚB; OSCC; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELLS; PGE(2); PROSTAGLANDIN E(2); REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; ROS; RT-PCR; TNF-Α; TUMOR NECROSIS FACTOR-Α; WESTERN BLOTTING;

ACTIVATOR PROTEIN-1; ANE; ANTIOXIDANT; AP-1; AQ; ARECA NUT EXTRACT; ARECA QUID; COX-2; CYCLOOXYGENASE-2; ELISA; ENZYME-LINKED IMMUNOSORBENT ASSAY; IL-1Α; IL-1Β; INTERLEUKIN-1Α; INTERLEUKIN-1Β; NF-ΚB; NONSTEROIDAL ANTI-INFLAMMATORY DRUGS; NSAIDS; NUCLEAR FACTOR-ΚB; ORAL SQUAMOUS CELL CARCINOMA; OSCC; PBMC; PDTC; PERIPHERAL BLOOD MONONUCLEAR CELLS; PGE(2); PROSTAGLANDIN E(2); PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; ROS; RT-PCR; TNF-Α; TUMOR NECROSIS FACTOR-Α;

ADULT; ARECA; BLOTTING, WESTERN; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1ALPHA; LEUKOCYTES, MONONUCLEAR; MALE; NF-KAPPA B; OXIDATIVE STRESS; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84888048833     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2013.05.006     Document Type: Article

References (44)

1. Gupta PC, Ray CS. Epidemiology of betel quid usage. Ann Acad Med Singapore 2004;33(Suppl. 4):31-6.
2. Wen CP, Tsai SP, Cheng TY, Chen CJ, Levy DT, Yang HJ, et al. Uncovering the relation between betel quid chewing and cigarette smoking in Taiwan. Tob Control 2005;14(Suppl. 1):i16-22.
3. IARC. Betel-quid and areca-nut chewing. IARC Monogr Eval Carcinog Risk Chem Hum 1985;37:141-200.
4. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 2001;37:477-92.
5. IARC. Betel-quid and areca-nut chewing and some arecanut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2004;85:1-334.
6. Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G, Gorgoulis VG. Advances in the biology of oral cancer. Oral Oncol 2007;43(6):523-34.
7. Department of Health (R.O.C. 2000). Cancer registration system annual report. Taipei, Taiwan: Department of Health, Executive Yuan; 2000.
8. Chang LY, Lin SC, Chang CS, Wong YK, Hu YC, Chang KW. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. J Oral Pathol Med 1999;28(9):389-96.
9. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol 1999; 35(2):173-9.
10. Chung CH, Yang YH, Wang TY, Shieh TY, Warnakulasuriya S. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med 2005;34 (8):460-6.
11. Chen Z, Malhorta PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999;5 (6):1369-79.
12. Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F. The feasibility of monitoring NF-κB associated cytokines: TNF-α, IL-1α, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 2005;44(2):77-82.
13. Haque MF, Harris M, Meghji S, Barrett AW. Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine 1998; 10(9):713-9.
14. Filer A, Pitzalis C, Buckley CD. Targeting the stromal microenvironment in chronic inflammation. Curr Opin Pharmacol 2006;6(4):393-400.
15. Tili E, Michaille J-J. Resveratrol, microRNAs, inflammation, and cancer. J Nucleic Acids 2011;2011:102431.
16. Trinchieri G. Innate inflammation and cancer: Is it time for cancer prevention? F1000 Med Rep 2011;3:11.
17. Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V. Multifaceted link between cancer and inflammation. Biosci Rep 2012;32:1-15.
18. 2-receptor subtypes in head and neck squamous carcinoma cell proliferation. Oral Oncol 2010;46 (12):880-7.
19. 2-dependent immunomodulation in breast cancer. Prostaglandins Other Lipid Mediat 2011;96(1-4):14-20.
20. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77 (8):1627-52.
21. Apte R, Dotan S, Elkabets M, White M, Reich E, Carmi Y, et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 2006;25(3):387-408.
22. Chen Z, Colon I, Ortiz N, Callister M, Dong G, Pegram MY, et al. Effects of Interleukin-1α, Interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res 1998;58(16):3668-76.
23. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007;117(5):1175-83.
24. Parsonnet J. Molecular mechanisms for inflammationpromoted pathogenesis of cancer. The sixteenth international symposium of the Sapporo cancer seminar (Sapporo, Japan, July 3-5, 1996). Cancer Res 1997;57(16):3620-4.
25. Chang LY, Wan HC, Lai YL, Kuo YF, Liu TY, Chen YT, et al. Areca nut extracts increased expression of inflammatory cytokines, tumor necrosis factor-α, interleukin-1β interleukin-6 and interleukin-8, in peripheral blood mononuclear cells. J Periodontal Res 2009; 44(2):175-83.
26. Chang LY, Wan HC, Lai YL, Liu TY, Hung SL. Enhancing effects of areca nut extracts on the production of interleukin-6 and interleukin-8 by peripheral blood mononuclear cells. J Periodontol 2006;77(12):1969-77.
27. Liu TY, Chen CL, Chi CW. Oxidative damage to DNA induced by areca nut extract. Mutat Res 1996;367:25-31.
28. Goldsby RA, Kindt TJ, Osborne BA. Cells and organs of the immune system. In: Goldsby RA, Kindt TJ, Osborne BA, editors. Kuby immunology. New York: W.H. Freeman and Company; 2000. p. 27-59.
29. Lai YL, Wu CY, Lee YY, Chang HW, Liu TY, Hung SL. Stimulatory effects of areca nut extracts on prostaglandin E2 production by human polymorphonuclear leukocytes. J Periodontol 2010;81(5):758-66.
30. Furutani Y, Notake M, Fukui T, Ohue M, Nomura H, Yamada M, et al. Complete nucleotide sequence of the gene for human interleukin-1α. Nucleic Acids Res 1986;14(8):3167-79.
31. Dave BJ, Trivedi AH, Adhvaryu SG. Role of areca nut consumption in the cause of oral cancers. A cytogenetic assessment. Cancer 1992;70(5):1017-23.
32. Shirname LP, Menon MM, Nair J, Bhide SV. Correlation of mutagenicity and tumorigenicity of betel quid and its ingredients. Nutr Cancer 1983;5(2):87-91.
33. Sundqvist K, Liu Y, Nair J, Bartsch H, Arvidson K, Graftstrom RC. Cytotoxic and genotoxic effects of areca nut related compounds in cultured human buccal epithelial cells. Cancer Res 1989;49:5294-8.
34. Tseng YH, Chang KW, Yang CC, Liu CJ, Kao SY, Liu TY, et al. Association between areca-stimulated vimentin expression and the progression of head and neck cancers. Head Neck 2012;34 (2):245-53.
35. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336(15):1066-71.
36. Haque MF, Meghji S, Khitab U, Harris M. Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med 2000;29(3):123-8.
37. Wang CC, Liu TY, Wey SP, Wang FI, Jan TR. Areca nut extract suppresses T-cell activation and interferon-g production via the induction of oxidative stress. Food Chem Toxicol 2007;45 (8):1410-8.
38. 4, and phosphorylation of p38 mitogen-activated protein kinase and elevated intracellular calcium concentrations in human polymorphonuclear leukocytes. J Periodontal Res 2007;42(5):393-401.
39. 2 production in oral cancer cell lines is COX-2-dependent. J Dent Res 2009;88(2):164-9.
40. Van Dyke TE. Control of inflammation and periodontitis. Periodontol 2000 2007;45(1):158-66.
41. 2 in periodontal disease. Periodontol 2000 2007;43(1):85-101.
42. Grandjean-Laquerriere A, Gangloff SC, Le Naour R, Trentesaux C, Hornebeck W, Guenounou M. Relative contribution of NF-κB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine 2002;18(3):168-77.
43. Nair UJ, Floyd RA, Nair J, Bussachini V, Friesen M, Bartsch H. Formation of reactive oxygen species and of 8-hydroxydeoxyguanosine in DNA in vitro with betel quid ingredients. Chem Biol Interact 1987;63(2):157-69.
44. Munoz C, Pascual-Salcedo D, Castellanos MC, Alfranca A, Aragones J, Vara A, et al. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-κB and AP-1 transcription factors activity. Blood 1996;88(9):3482-90.